Envestnet Portfolio Solutions Inc. raised its holdings in shares of Hamilton Lane Inc. (NASDAQ: HLNE) by 116.7% in the second quarter, according to its most recent Form 13F filing with the SEC. The in
Envestnet Portfolio Solutions Inc. grew its position in shares of White Mountains Insurance Group, Ltd. (NYSE: WTM) by 13.9% during the second quarter, according to its most recent filing with the SEC
Envestnet Portfolio Solutions Inc. reduced its holdings in shares of Fidelity National Information Services, Inc. (NYSE: FIS) by 15.4% during the undefined quarter, according to its most recent 13F fi
Envestnet Portfolio Solutions Inc. trimmed its position in iShares MSCI China ETF (NASDAQ: MCHI) by 38.3% during the second quarter, according to the company in its most recent 13F filing with the Sec
LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today presents on the positive interim ef
Envestnet Portfolio Solutions Inc. boosted its position in Vanguard FTSE Europe ETF (NYSEARCA:VGK) by 75.4% in the second quarter, according to its most recent filing with the SEC. The institutional i
NEW YORK--(BUSINESS WIRE)--CAIS, the leading alternative investment platform for independent financial advisors, today announced expanded strategic partnerships with Envestnet, Orion, and Vestmark—t
LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces positive efficacy data fr
LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces participation and present
Delray Beach, FL, Aug. 22, 2025 (GLOBE NEWSWIRE) -- According to MarketsandMarkets™, the Open Banking Solutions Market size is expected to grow from USD 5.5 billion in 2023 to USD 11.7 billion by 20
LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American:KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces positive safety results fr
Wealth technology provider Envestnet plans to sell its open finance and data analytics subsidiary, Yodlee, to private equity firm STG. [contact-form-7] The transaction is expected to close in the th
LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA) is a clinical stage company involved in treating EGFR-driven lung cancer patients with ENV105 in combination with osimertinib af
LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company (the “Company'”), announces the completion of the safety lead-in of its Phase 2
BERWYN, Pa. , March 3, 2025 /PRNewswire/ -- Key Wealth, the wealth management business of KeyBank and Envestnet, a leading provider of integrated technology, intelligent data, and wealth solutions, a
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE